June 2013 FDA Recall Amoxicillin by Teva Pharmaceuticals Usa, Inc.
D-803-2013 - Discoloration

This Class III drug recall was voluntarily initiated by Teva Pharmaceuticals Usa, Inc. on June 18, 2013 for the product Amoxicillin. The FDA reported the reason for recall as discoloration. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-803-2013

Reason for Recall
Discoloration: This recall is being carried out due to an orange to brown discolored Amoxicillin powder on the inner foil seal of the bottles. This is an expansion of RES 65050.
Initiated
06-18-2013
Reported
07-24-2013
Quantity
109,080 Bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Teva Pharmaceuticals USA, Inc.
Amoxicillin for Oral Suspension, USP 200 mg/5 mL, a) 75 mL bottle NDC 0093-4160-78 and b) 100 mL bottle NDC 0093-4160-73, Rx Only, Manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B2K9, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960.

Batch or Lot Expiration Information

Lot# s: a) 35426557A, 35426558A, Exp 08/14; b) 35426554A, 35426555A, 35426556A, Exp 08/14